Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
AIM ImmunoTech Announces Launch of CEO Corner Platform
CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested parties the ability to ask questions and submit topics for future videosAccess the AIM CEO Corner Here! OCALA, Fla., March07, 2024(GLOBE NEWSWIRE) -- AIM ImmunoTech Inc.(NYSE American: AIM) (“AIM” or the “Company”), today announced the launch of itsCEO CornerfeaturingThomas K Equels, M.S., J.D., Executive Vice Chairman, Chief...
Nasdaq GlobeNewswire
07/03/2024
BioNTech Announces Planned Retirement of Sean Marett
Mainz, Germany, March 7, 2024 (GLOBE NEWSWIRE)– BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Sean Marett, Chief Business and Commercial Officer, will retire as planned from the Management Board of BioNTech. As of July 1, 2024, Sean Marett will continue as a specialist advisor to the Company at least until the end of the year. A new Chief Commercial Officer will be announced by the end of March 2024. Sean Marett's responsibilities as Chief Business Officer...
Nasdaq GlobeNewswire
07/03/2024
Maracuja Oil Market Expected to Reach $4,220.5 Million by 2032--Allied Market…
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/4000 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/4000 Prime determinants of growth The growing demand for organic and natural products is driving the growth of the maracuja oil market. However, the growth of the maracuja oil market is restricted by the limited availability of products in different regions. On the other hand, expanding...
PR Newswire
07/03/2024
Gabather reports initial positive results from the EEG/fMRI target engagement…
Clinically relevant effects of GT-002 were observed on modulation of EEG frequency band power with a significant increase in alpha band power, compared to Lorazepam at the 2-hour after treatment. This effect spanned various brain regions, including frontal and occipital areas. No significant effect of Lorazepam on EEG alpha band power compared to placebo was observed. The results suggest a distinct effect of GT-002 to modulate alpha band power across specific cortical regions. Clinically...
PR Newswire
07/03/2024
Nexstim Plc: Invitation to the Annual General Meeting
Company announcement, Helsinki, 7 March 2024 at 10 AM (EET)Nexstim Plc: Invitation to the Annual General Meeting Nexstim Plc (NXTMH:HEX) (“Nexstim” or the “Company”) is pleased to invite shareholders to the Annual General Meeting of the Company on March 28, 2024, commencing at 10:00 am (EEST) at Nexstim's head office, Elimäenkatu 9 B (courtyard), 4th floor, 00510 Helsinki. The reception of persons who have registered for the meeting will commence at 9:30. There will be no coffee...
Nasdaq GlobeNewswire
07/03/2024
US FDA grants Orphan Drug Designation for iOnctura's first-in-class autotaxin…
Following a separate submission process the World Health Organization has proposed the International Nonproprietary Name (INN) of cambritaxestat. Following a separate submission process the World Health Organization has proposed the International Nonproprietary Name (INN) of cambritaxestat. Cambritaxestat is being developed as a first-in-class therapy for highly fibrotic cancer indications. The drug's lead indication is metastatic pancreatic cancer where it is being combined with standard of...
PR Newswire
07/03/2024
Highlights to be presented at Novo Nordisk's Capital Markets Day 2024
Bagsværd, Denmark, 7 March 2024– Novo Nordisk is today hosting a Capital Markets Day (CMD) where the company is providing a progress update on its Strategic Aspirations 2025. The day will be centred around the Strategic Aspirations. During the day, senior management presentations will cover corporate strategy and purpose & sustainability (ESG), Research and early development, Product Supply as well research and development pipeline and performance within Diabetes care, Obesity care...
Nasdaq GlobeNewswire
07/03/2024
Calyx and Invicro agree to combine to create a global leader in medical imaging…
Calyx and Invicro each provide complementary services to most of the world's leading pharma and biotechnology companies. The Group will employ approximately 2,000 highly skilled employees across ten sites, throughout the US, Europe and Asia, thereby having the ability to provide a full suite of solutions to its clients across the world. The combination unites deep heritage and extensive experience reflected in combined support for almost 12,000 clinical and research trials to date, across all…
PR Newswire
07/03/2024
Ultimovacs Announces Topline Results from INITIUM Study Evaluating UV1…
With the 18-month minimum follow-up of the patients in the INITIUM trial, the trial did not meet the primary endpoint of prolonging progression-free survival (PFS). Median PFS was not reached in either arm. Evaluation of secondary endpoints did not show a difference in overall survival and objective response rate between the treatment and control armsUV1 maintained its positive safety profile with similar safety and tolerability as observed in the control armUltimovacs remains confident...
Nasdaq GlobeNewswire
07/03/2024
BioArctic's partner Eisai presents updated sales simulation for Leqembi® at its…
This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons below, on March 7, 2023, at 06:30 a.m. CET. This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons below, onMarch...
PR Newswire
07/03/2024
A Global Milestone in Innovative Pancreatic Cancer Therapy
Pancreatic cancer affects 500,000 people globally each year, with over 3,000 cases in Taiwan annually. It is difficult to diagnose early due to its inconspicuous initial symptoms, so most patients are diagnosed at advanced stages. According to the latest statistics from the National Institutes of Health (NIH) in the United States, the five-year survival rate for pancreatic cancer with distant metastasis is only 3.2%, making it the deadliest cancer. Current treatments primarily involve…
PR Newswire
07/03/2024
LG UNVEILS BRAND-NEW DUALCOOL AIR CONDITIONER AT MCE 2024 IN MILAN
With its sophisticated 'interior fit' design and refined matte finish, the latest LG DUALCOOL air conditioner is a stylish addition to the home. The advanced, new model integrates a dual outlet structure that delivers fast, optimized temperature control and gentle, indirect airflow that won't leave users feeling chilly. Equipped with the efficient and reliable Dual Inverter Heat Pump Compressor™, LG's innovative air conditioner performs reliably in any season and boasts an EU energy efficiency…
PR Newswire
07/03/2024
Nanobiotix to Present at Upcoming Investor Conferences in March
PARIS and CAMBRIDGE, Mass., March06, 2024(GLOBE NEWSWIRE) --NANOBIOTIX(Euronext: NANO –– NASDAQ: NBTX – the '' Company ''), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announced today that Company management will participate in fireside chats at the upcoming Guggenheim Healthy Altitudes Summit and the Leerink Partners Global Biopharma Conference. Please see below for details on each event...
Nasdaq GlobeNewswire
06/03/2024
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
__________ __________ CONSOLIDATED FINANCIAL RESULTS Total revenues were$498 millionin fourth-quarter 2023, a decrease of 10% compared to$556 millionin fourth-quarter 2022. This decrease was primarily attributable to decreased revenues from the Generic Pharmaceuticals and Sterile Injectables segments, partially offset by increased revenues from the Branded Pharmaceuticals segment. Reported loss from continuing operations in fourth-quarter 2023 was$2,441 millioncompared to...
PR Newswire
06/03/2024
AB Science announces that two financial analysis firms, DNA Finance and In…
PRESS RELEASETWO NEW FINANCIAL ANALYSIS FIRMS INITIATE COVERAGE OF AB SCIENCEParis, March 6, 2024, 8.15pm CETAB Science SA(Euronext - FR0010557264 - AB) announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated the coverage of the Company.DNA Finance estimates that AB Science stands out as a compelling investment opportunity in the biotech sector.In Extenso has initiated a strong buy opinion on the share.These new coverages aim to...
Nasdaq GlobeNewswire
06/03/2024
The US Elderly Care Market to Reach Revenue of Over USD 651.48 Billion by 2029…
The U.S. Elderly Care Market Report Scope The U.S. Elderly Care Market Report Scope This report offers market size & forecast data for the elderly care services market in the U.S. The revenue generated from service offerings is included in the report. This report provides a comprehensive and current market scenario of the U.S. elderly care services market, including the U.S. elderly care services market size, anticipated market forecast, relevant market segmentations, and industry...
PR Newswire
06/03/2024
Mental Health Screening Market Worth $1.8 billion | MarketsandMarkets™.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198516770 Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198516770 Browse in-depth TOC on "Mental Health Screening Market" 644 - Tables 46 - Figures 551 - Pages Mental Health Screening Market Scope: Cognitive Disorders is the fastest growing in the Mental Health Screening market in 2023. Based on applications, the mental...
PR Newswire
06/03/2024
Interior Design Market Size to Grow USD 317870 Million by 2030 at a CAGR of 8.3%…
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-31M606/Global_Interior_Design Get Free Sample:https://reports.valuates.com/request/sample/QYRE-Auto-31M606/Global_Interior_Design Major Factors Driving the Growth of Interior Design Market Rapid urbanization, changing consumer preferences, technological advancements enabling design innovation, and a growing focus on sustainability are some of the factors driving the interior design market's growth. These...
PR Newswire
06/03/2024
Clinical Trial Equipment & Ancillary Solutions Market to reach over US$ 5.16…
List of Prominent Players in the Clinical Trial Equipment & Ancillary Solutions Market: List of Prominent Players in the Clinical Trial Equipment & Ancillary Solutions Market: Recent Developments: Request for Sample Pages:https://www.insightaceanalytic.com/request-sample/2326 The global market has experienced significant expansion propelled by increased investments in research and development, the growing necessity for clinical trials, and the rapid expansion of the...
PR Newswire
06/03/2024
Customized Probiotics Market to Record an Exponential CAGR by 2031 - Exclusive…
Customized probiotics refer to probiotic formulations tailored to an individual's specific needs or health conditions. These formulations can be designed based on a person's unique gut microbiota composition, health status, dietary habits, or specific health goals. The customization process might involve selecting specific strains of beneficial bacteria that are known to address particular health issues or to enhance overall gut health. Customized probiotics refer to probiotic formulations...
PR Newswire
06/03/2024
Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance
This submission is via the 510k regulatory pathway for medical devices. Notably, the Epitomee® capsule has already received approval in the European Union and bears a CE mark. Upon FDA approval, the capsule will become available by prescription from healthcare professionals. This submission is via the510kregulatory pathway for medical devices. Notably, the Epitomee® capsule has already received approval in the European Union and bears a CE mark. Upon FDA approval, the capsule will become...
PR Newswire
06/03/2024
Coloplast A/S - Trading in Coloplast shares by board members, executives or…
Please see enclosed pdf. Attachment 06032024_trading_in_shares_ASL
Nasdaq GlobeNewswire
06/03/2024
Coloplast A/S - Trading in Coloplast shares by board members, executives or…
Please see enclosed pdf. Attachment 06032024_trading_in_shares_KVI
Nasdaq GlobeNewswire
06/03/2024
Signant Health Unveils Next-Level Advancements in Efficient, Compliant IP…
Signant's GxP Inventory solution centralizes visibility and control of clinical trial material creation, release, and distribution activities within a single system, and serves as a unified system of record for manufacturing and distribution. Signant's GxP Inventory solution centralizes visibility and control of clinical trial material creation, release, and distribution activities within a single system, and serves as a unified system of record for manufacturing and distribution. A newly...
PR Newswire
06/03/2024
Altri Comunicati
